Cencora, Inc. - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
COR New York 8081 www.cencora.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cencora, Inc.

Q2 Earnings Outperformers: Cencora (NYSE:COR) And The Rest Of The Health Insurance Providers Stocks - Sep 8th, 2026 2:23 pm
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - Sep 4th, 2026 1:39 pm
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - Sep 4th, 2026 12:50 pm
Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue? - Sep 4th, 2026 9:30 am
Cencora Launches Cell and Gene Therapy Enablement for Health Systems - Sep 4th, 2026 7:37 am
Is Cencora (COR) Still Undervalued On Higher 2026 Guidance And Strong Q3 Earnings? - Sep 4th, 2026 1:07 am
What Cencora (COR)'s Cell and Gene Push and Higher 2026 Outlook Means For Shareholders - Sep 3rd, 2026 4:40 pm
Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore” - Sep 3rd, 2026 3:52 pm
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen - Sep 3rd, 2026 1:22 pm
Artisan Sold Cencora (COR) as Earnings Momentum Slowed - Sep 3rd, 2026 7:11 am
Is Generics Still a Quiet Profit Engine for Cardinal Health? - Sep 3rd, 2026 6:22 am
Cencora’s Accelerate Pharmacy Solutions Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs - Sep 2nd, 2026 6:30 am
Beat the Market the Zacks Way: Accelerant, Insight, General Mills in Focus - Aug 31st, 2026 6:28 am
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? - Aug 29th, 2026 11:41 am
Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - Aug 29th, 2026 10:05 am
Camino Closes $5.8 Million Brokered Private Placement of Units and Concurrent $9.4 Million Non-Brokered Private Placement of Convertible Debentures - Aug 26th, 2026 9:40 am
Is McKesson Stock Worth Buying as Growth Meets a Premium Valuation? - Aug 24th, 2026 12:49 pm
McKesson Raises FY27 Guidance as Oncology and GLP-1 Growth Accelerate - Aug 24th, 2026 12:49 pm
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - Aug 14th, 2026 1:46 pm